| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | IMMUNIC, INC. | 4,335,255 | 9.6% | EDGAR |
| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | IMMUNIC, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | COMMODORE CAPITAL LP | IMMUNIC, INC. | 0 | 0.0% | EDGAR |
| SC 13G | 2024-01-18 | BIOTECHNOLOGY VALUE FUND L P | IMMUNIC, INC. | 4,665,158 | 5.2% | EDGAR |
| SC 13G | 2024-01-18 | JANUS HENDERSON GROUP PLC | IMMUNIC, INC. | 6,693,007 | 7.4% | EDGAR |
| SC 13G | 2024-01-16 | Avidity Partners Management LP | IMMUNIC, INC. | 8,899,418 | 9.9% | EDGAR |
| SC 13G | 2024-01-10 | Soleus Private Equity Fund III, L.P. | IMMUNIC, INC. | 4,895,105 | 5.4% | EDGAR |
| SC 13D/A | 2023-02-24 | LSP V Cooperatieve U.A. | IMMUNIC, INC. | 2,162,782 | 4.9% | EDGAR |
| SC 13G/A | 2023-02-14 | RTW INVESTMENTS, LP | IMMUNIC, INC. | 3,861,290 | 8.7% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | IMMUNIC, INC. | 4,022,989 | 8.3% | EDGAR |
| SC 13G/A | 2023-02-14 | COMMODORE CAPITAL LP | IMMUNIC, INC. | 2,873,563 | 6.3% | EDGAR |
| SC 13D/A | 2023-02-13 | Global Life Bioventure V Sarl | IMMUNIC, INC. | 1,788,160 | 4.0% | EDGAR |
| SC 13G | 2022-11-28 | Oetker-von Franquet Suzanne Madeleine | IMMUNIC, INC. | 1,974,571 | 5.0% | EDGAR |
| SC 13G | 2022-11-25 | Oetker Roland | IMMUNIC, INC. | 1,974,571 | 5.0% | EDGAR |
| SC 13G | 2022-11-25 | ROI VERWALTUNGS GMBH | IMMUNIC, INC. | 1,974,571 | 5.0% | EDGAR |
| SC 13G | 2022-10-24 | Point72 Asset Management, L.P. | IMMUNIC, INC. | 1,911,929 | 4.9% | EDGAR |
| SC 13G | 2022-10-21 | COMMODORE CAPITAL LP | IMMUNIC, INC. | 3,766,576 | 9.3% | EDGAR |
| SC 13G | 2022-10-20 | Deep Track Capital, LP | IMMUNIC, INC. | 4,022,989 | 9.3% | EDGAR |
| SC 13D/A | 2022-03-15 | Global Life Bioventure V Sarl | IMMUNIC, INC. | 1,788,160 | 9.0% | EDGAR |
| SC 13G | 2022-02-14 | RTW INVESTMENTS, LP | IMMUNIC, INC. | 1,715,470 | 6.5% | EDGAR |